Home Alzheimer’s Disease FDA Approves Nivolumab Plus Ipilimumab with Chemotherapy for NSCLC

FDA Approves Nivolumab Plus Ipilimumab with Chemotherapy for NSCLC

The FDA has approved the use of nivolumab (Opdivo) plus ipilimumab (Yervoy) given with 2 cycles of platinum-doublet chemotherapy as a first-line treatment for adult patients with metastatic or recurrent non-small cell lung cancer (NSCLC) with no EGFR or ALK genomic tumor aberrations, according to Bristol Myers Squibb, the developer of the agents.  

The therapy has been approved for patients with squamous or non-squamous disease, regardless of PD-L1 expression. 

Previously on May 15, the FDA approved the combination as a first-line treatment for certain patients with metastatic NSCLC whose tumors express PD-L1 ≥ 1% as determined by an FDA-approved test. 

“Non-small cell lung cancer is a complex disease that requires multiple treatment options to address the needs of different patient populations,” Adam Lenkowsky, general manager and head of Oncology, Immunology, and…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Reflections on Living With an Incurable Illness : braincancer

(I’ve checked with the moderators to make sure this is appropriate and a good fit for this subreddit. I'm a very private person, and...

This Foramen Magnum Meningioma almost killed me 18 years ago.

submitted by /u/dkrem Continue Reading to the Source

Patients, Family & Friends, and Healthcare professionals : braincancer

I am currently a PhD student based at the Marie Curie Palliative Care Research Centre at Cardiff University. My PhD is focussed on developing...

32 year old singer Tom Parker of The Wanted diagnosed with stage 4 glioblastoma

submitted by /u/Jexlan Continue Reading to the Source

Recent Comments